Singapore, August 8, 2012 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has received Notice of Allowance from the Chinese State Intellectual Property Office for its Micro-channel Avalanche Photodiode (MAPD) solid-state photo detector.   The Chinese Notification for Patent is the second patent granted for the MAPD solid-state photo detector, the first patent was granted by Russia in March 2008.  Patents have been filed and are pending in other jurisdictions including the United States.

"Our MAPD solid-state photo-detectors are gaining market share with prestigious institutions such as CERN and are key alternative components for the development of new generation PET scanners, making the protection of the underlying MAPD technology of paramount importance,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc.  “The MAPD is now patented in Russian and China and patents are pending in other countries including the United States.  We will continue to be vigilant with respect to the security of our technologies patent portfolio.”

Zecotek’s proprietary MAPD-3N is a design upgrade of the previously announced MAPD. It offers significant performance-cost advantages over competing photomultiplier tubes (PMT) and other solid-state, silicon based photo-detectors. Its good recovery time, its unique radiation hardness and its display of the highest possible linearity, make it a prime component for the improved detector designs required in the next crucial phase of high energy experiments at CERN. Its low manufacturing cost, excellent timing resolution and Photon Detection Efficiency are key characteristics for the new configurations of high resolution PET (Positron Emission Tomography) scanners.

The MAPD-3N is supplied to customers through Zecotek Imaging Systems Pte. Ltd., Singapore, a wholly owned subsidiary of Zecotek Photonics Inc., and manufactured under contract by the National NanoFab Center, Daejeon City, South Korea.

-30-

About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanner technologies, 3D auto-stereoscopic displays, fiber lasers and waveguide micro lasers for applications in medical, high-tech and industrial sectors.  Founded in 2003, Zecotek operates three divisional companies:  Zecotek Imaging (medical, industrial and research), Zecotek Lasers (industrial and research) and Zecotek 3D (monitors for multimedia, entertainment, industrial and medical). The Company has labs located in Canada, Singapore and Russia, with affiliated R&D and production facilities in USA, China, and South Korea.  Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances with multinational OEMs, distributors and other industry leaders.  For more information, visit www.zecotek.com.

This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.

For Additional Information Please Contact:

Zecotek Photonics Inc.        Michael Minder T: (604) 783-8291    ir@zecotek.com

CHF Investor Relations Julia Clark, Account Manager T: (416) 868-1079 x236 julia@chfir.com

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.